Search research articles
Contact Us
Filters
Showing results (51-60 of 209) with videos related to
Page
of 21
Sort By:
Journal of Nutritional Science and Vitaminology
|
December 1, 1991
Effect of dietary protein restriction on proteinuria in non-insulin-dependent diabetic patients with nephropathy
T Sugimoto, R Kikkawa, M Haneda, et al.
Biochemical and Biophysical Research Communications
|
August 31, 1993
Atrial natriuretic peptide inhibits endothelin-1-induced activation of mitogen-activated protein kinase in cultured rat mesangial cells
T Sugimoto, R Kikkawa, M Haneda, et al.
Diabetes
|
July 1, 1972
Lack of ketosis in lipoatrophic diabetes
R Kikkawa, M Hoshi, Y Shigeta, et al.
Biofactors (Oxford, England)
|
April 2, 1998
d-alpha-tocopherol treatment prevents glomerular dysfunctions in diabetic rats through inhibition of protein kinase C-diacylglycerol pathway
D Koya, M Haneda, R Kikkawa, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
December 24, 1997
Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells
Y Nishio, A Kashiwagi, N Takahara, et al.
Biochimica Et Biophysica Acta
|
March 14, 1986
Effect of angiotensin II infusion on glomerular angiotensin II receptor in rats
E Kitamura, R Kikkawa, Y Fujiwara, et al.
Diabetes
|
March 17, 1999
Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase
T Ishida, M Haneda, S Maeda, et al.
Journal of the Neurological Sciences
|
January 6, 2000
Evaluation of diabetic neuropathy through the quantitation of cutaneous nerves
A Hirai, H Yasuda, M Joko, et al.
Kidney International
|
May 7, 1999
TGF-beta 1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells
K Inoki, M Haneda, S Maeda, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1995
Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study
Y Goto, N Hotta, Y Shigeta, et al.
Page
of 21
Search research articles
Search
Showing results (51-60 of 209) with videos related to
Sort By:
Page
of 21
Journal of Nutritional Science and Vitaminology
|
December 1, 1991
Effect of dietary protein restriction on proteinuria in non-insulin-dependent diabetic patients with nephropathy
T Sugimoto, R Kikkawa, M Haneda, et al.
Biochemical and Biophysical Research Communications
|
August 31, 1993
Atrial natriuretic peptide inhibits endothelin-1-induced activation of mitogen-activated protein kinase in cultured rat mesangial cells
T Sugimoto, R Kikkawa, M Haneda, et al.
Diabetes
|
July 1, 1972
Lack of ketosis in lipoatrophic diabetes
R Kikkawa, M Hoshi, Y Shigeta, et al.
Biofactors (Oxford, England)
|
April 2, 1998
d-alpha-tocopherol treatment prevents glomerular dysfunctions in diabetic rats through inhibition of protein kinase C-diacylglycerol pathway
D Koya, M Haneda, R Kikkawa, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
December 24, 1997
Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells
Y Nishio, A Kashiwagi, N Takahara, et al.
Biochimica Et Biophysica Acta
|
March 14, 1986
Effect of angiotensin II infusion on glomerular angiotensin II receptor in rats
E Kitamura, R Kikkawa, Y Fujiwara, et al.
Diabetes
|
March 17, 1999
Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase
T Ishida, M Haneda, S Maeda, et al.
Journal of the Neurological Sciences
|
January 6, 2000
Evaluation of diabetic neuropathy through the quantitation of cutaneous nerves
A Hirai, H Yasuda, M Joko, et al.
Kidney International
|
May 7, 1999
TGF-beta 1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells
K Inoki, M Haneda, S Maeda, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1995
Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study
Y Goto, N Hotta, Y Shigeta, et al.
Page
of 21